Aluminium hydroxide

Generic Medicine Info
May be taken with or without food.
Hypophosphataemia, acute porphyria.
Special Precautions
Patient w/ restricted phosphate intake, low Na diet, uraemia, heart failure, oedema, recent GI haemorrhage. Hepatic (e.g. cirrhosis) and renal (e.g. chronic renal failure) impairment. Pregnancy. Patient Counselling Avoid application over deep and puncture wounds, infected areas, or lacerations. Monitoring Parameters Monitor serum Ca and phosphate levels regularly when patient is on chronic therapy.
Adverse Reactions
Constipation, intestinal obstruction, faecal discolouration and impaction, nausea, vomiting, stomach cramps; hypomagnesaemia, hypophosphataemia.
Drug Interactions
May interfere w/ the absorption of some drugs including tetracyclines, penicillin, sulfonamides, Fe, digoxin, indometacin, naproxen, phenylbutazone, quinidine and vit. Absorption is enhanced by citrates or ascorbic acid.
CIMS Class
Antacids, Antireflux Agents & Antiulcerants
ATC Classification
A02AB01 - aluminium hydroxide ; Belongs to the class of aluminium-containing antacids.
Disclaimer: This information is independently developed by CIMS based on aluminium hydroxide from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in